Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer

Figure 4

Survival analysis of all liver cancer patients (a) and subgroup analysis based on clinical stage (stage I/II and stage III/VI) (b, c), histological grade (G1/2 and G3/4) (d, e), and TNM classification (T1/2, T3/4, N0, N1, M0, M1) (f–k). Red curve indicates high CEP55 expression; blue curve indicates low CEP55 expression.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)